Paul E. Wakely

213 papers receiving 4.5k citations

Paul E. Wakely's Hit Papers

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer 2009 · 430 citations
4300+5+11Years since publication100200300400

Peers

Paul E. Wakely
Comparison fields: 5 of 94
  • Otorhinolaryngology 334
  • Endocrinology, Diabetes and Metabolism 887
  • Rheumatology 699
  • Pathology and Forensic Medicine 654
  • Pulmonary and Respiratory Medicine 1.2k
Replace Edward B. Stelow with:
Edward B. Stelow United States
Paolo Gattuso United States
Justin A. Bishop United States
Alfred Beham Austria
Louis H. Weiland United States
Douglas R. Gnepp United States
CDM Fletcher United States
Thom R. Loree United States
R. V. P. Hutter United States
Akitaka Nonomura Japan
Paul E. Wakely relative to Edward B. Stelow United States Edward B. Stelow's profile →
Citations per field
00.5×1.5×2.0×
Edward B. Stelow · 1×
Citations per year

Countries citing papers authored by Paul E. Wakely

Since Specialization
Citations

This map shows the geographic impact of Paul E. Wakely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Wakely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Wakely more than expected).

Fields of papers citing papers by Paul E. Wakely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Wakely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Wakely. The network helps show where Paul E. Wakely may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul E. Wakely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul E. Wakely Line = papers co-authored together Paul E. Wakely links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Hit paper breakdown →
2009430
2 2012292
3 2010288
4 2006146
5 2003145
6 198795
7 199588
8 201182
9 200073
10 201369
11 198862
12 200058
13 200950
14 201547
15 201747
16 199143
17 199142
18 198942
19 199641
20 199739

About Paul E. Wakely

Paul E. Wakely is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Rheumatology, Oncology and Pathology and Forensic Medicine, having authored 221 papers that have together received 4.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (42 papers), Salivary Gland Tumors Diagnosis and Treatment (26 papers), Soft tissue tumor case studies (20 papers), Lymphoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (18 papers), Vascular Tumors and Angiosarcomas (16 papers), Thyroid Cancer Diagnosis and Treatment (13 papers) and Neuroblastoma Research and Treatments (11 papers). The work is most often cited by research in Otorhinolaryngology (334 citations), Endocrinology, Diabetes and Metabolism (887 citations), Rheumatology (699 citations), Pathology and Forensic Medicine (654 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Paul E. Wakely has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include William J. Frable, Joel Mayerson, Syed Z. Ali, Saul Suster, Matthew D. Ringel, Jeffrey S. Kneisl, Motoyasu Saji, Richard T. Kloos, Nathan C. Hall and Manisha H. Shah. Their work appears in journals such as Cancer Cytopathology, Cancer, Diagnostic Cytopathology, American Journal of Clinical Pathology and Head and Neck Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact